iBio (NYSE: IBIO) schedules 2026 meeting, updates proposal deadlines
Rhea-AI Filing Summary
iBio, Inc. plans to hold its 2026 Annual Meeting of Stockholders on October 14, 2026, with stockholders of record at the close of business on September 1, 2026 entitled to vote. The specific time and location will be provided in the definitive proxy statement.
Because this meeting date is more than 30 days earlier than the 2025 annual meeting, previously disclosed proposal deadlines no longer apply. Stockholder proposals for inclusion in the proxy materials under Rule 14a-8 must be received by August 1, 2026. Proposals or director nominations not under Rule 14a-8, submitted under the company’s bylaws, must be received by July 27, 2026. To comply with universal proxy rules, stockholders soliciting proxies for alternative director nominees must provide the notice required by Rule 14a-19 by August 15, 2026, 60 days before the meeting date.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.08, 8.01, 9.01
3 items
Item 5.08
Shareholder Director Nominations
Governance
Shareholder nominations for board of directors under proxy access rules. Rarely used -- the underlying SEC rule was vacated.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
2026 Annual Meeting date: October 14, 2026
Record date: September 1, 2026
Rule 14a-8 proposal deadline: August 1, 2026
+3 more
6 metrics
2026 Annual Meeting date
October 14, 2026
Scheduled date of the 2026 Annual Meeting of Stockholders
Record date
September 1, 2026
Close of business date determining stockholders entitled to vote
Rule 14a-8 proposal deadline
August 1, 2026
Last date for inclusion of proposals in 2026 proxy materials
Bylaw proposal/nomination deadline
July 27, 2026
Tenth day following public disclosure of the 2026 meeting date
Universal proxy notice deadline
August 15, 2026
60 days prior to the 2026 Annual Meeting for Rule 14a-19 notices
Meeting timing vs prior year
More than 30 days
2026 Annual Meeting date is more than 30 days before 2025 anniversary date
Key Terms
Rule 14a-8, Second Amended and Restated Bylaws, universal proxy rules, Rule 14a-19, +1 more
5 terms
Rule 14a-8 regulatory
"stockholder proposals pursuant to Rule 14a-8 ("Rule 14a-8") under the Exchange Act"
Rule 14a-8 is a U.S. Securities and Exchange Commission regulation that lets eligible shareholders put proposals on a public company’s proxy ballot for an annual meeting, provided they meet basic ownership and filing requirements. It matters to investors because it creates a formal way to raise governance or strategic issues and force a company-wide vote—like getting an item onto the agenda of a neighborhood association meeting once you’ve lived there long enough—so shareholders can push for change or influence management decisions.
Second Amended and Restated Bylaws regulatory
"Pursuant to the Company’s Second Amended and Restated Bylaws, because the scheduled date"
universal proxy rules regulatory
"In addition, to comply with the universal proxy rules, stockholders who intend to solicit"
Universal proxy rules require that when shareholders vote to elect directors in a contested election, the proxy card mailed to investors can include candidates nominated by both the company and dissident shareholders, letting investors mix and match their choices on a single ballot. This matters to investors because it makes their vote more flexible and easier to use, like replacing separate lists with one common ballot, which can influence who controls the board and the company’s future direction.
Rule 14a-19 regulatory
"must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act"
Rule 14a-19 is a U.S. Securities and Exchange Commission rule that governs how independent proxy advisory firms produce and distribute voting recommendations for shareholders. It requires these advisers to provide companies with notice of their recommendations and a chance to respond, and to disclose certain conflicts; think of it as a referee ensuring both sides see a game plan before fans cast votes. Investors care because proxy advisers influence voting outcomes and corporate governance, so the rule affects transparency, potential bias, and the reliability of guidance that many investors rely on when voting shares.
record date financial
"set the record date for determining the stockholders of record who will be entitled to vote"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
When is iBio (IBIO) holding its 2026 Annual Meeting of Stockholders?
iBio plans to hold its 2026 Annual Meeting of Stockholders on October 14, 2026. The company states that the precise time and location will be provided in its definitive proxy statement filed with the SEC ahead of the meeting.
What is the record date for voting at iBio (IBIO)'s 2026 Annual Meeting?
The record date for iBio’s 2026 Annual Meeting is September 1, 2026, at the close of business. Only stockholders of record as of that date will be entitled to receive notice of and vote at the 2026 Annual Meeting.
What is the deadline for non-Rule 14a-8 proposals or nominations at iBio (IBIO)?
For proposals or director nominations not seeking inclusion under Rule 14a-8, iBio requires receipt by July 27, 2026. These must be delivered to the principal executive office and include all information specified in the company’s Second Amended and Restated Bylaws.
What are iBio (IBIO)'s universal proxy notice requirements for 2026 director nominees?
Stockholders intending to solicit proxies for director nominees other than iBio’s own must provide the information required by Rule 14a-19 by August 15, 2026. This deadline is 60 days before the October 14, 2026 annual meeting date.
Why did iBio (IBIO) reset its previously disclosed 2026 proposal deadlines?
The 2026 Annual Meeting is scheduled more than 30 days earlier than the 2025 annual meeting anniversary, so earlier proposal deadlines no longer apply. iBio has therefore provided revised dates for Rule 14a-8 proposals, bylaw proposals, and universal proxy notices.